FDA Drug recall D-1333-2022
SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519…
- FDA Drug
- Class I
- terminated
- Published 2022-08-10
On 2022-08-10 the FDA classified a Class I recall of SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519… by Distributor Rfr, citing marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1333-2022 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-07-22 |
| Published | 2022-08-10 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Distributor Rfr |
| Distribution | US |
Product
SANGTER Energy Supplement Capsules, 3000mg x 7 grain, 7-count blister pack within a carton, Distributed by: Distributor RFR, LLC, (800) 519-0204 Miami 33172 FL, USA; UPC 0 705632 523285
Reason
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
Identifiers
| upc | 0705632523285 |
|---|---|
| code_info | Lot: 48656, Exp. 01/2025 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1333-2022%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.